LongueVue Capital Invests in Summit Clinical Research

Summit Clinical Research (with Pinnacle) Acquires Houston Research Institute

February 28, 2025

Healthcare Services

LongueVue Capital portfolio company Summit Clinical Research, in partnership with Pinnacle Clinical Research, completed a strategic investment in Houston Research Institute (HRI) to expand Summit's metabolic/hepatology clinical research capabilities. The transaction brings HRI's scientific expertise into Summit/Pinnacle's site network and is accompanied by leadership additions — Dr. Mazen Noureddin named Co-Chairman (and Chief Scientific Officer), Dr. Naim Alkhouri as Chief Academic Officer, and Brandon Early as President.

LongueVue Capital portfolio company Pinnacle Clinical Research completes acquisitions of five clinical research sites

June 18, 2024

Healthcare Services

LongueVue Capital’s portfolio company Pinnacle Clinical Research has completed investments/acquisitions of five clinical research sites: Kerwin Medical Center, The Cognitive and Research Center of New Jersey, Bellaire Clinical Research, Palmetto Clinical Research – Low Country, and Dallas Research Institute. The additions broaden Pinnacle’s U.S. geographic footprint and expand therapeutic-area expertise, including central nervous system focus for Alzheimer’s disease indications via Kerwin Medical Center and CRCNJ.

Pinnacle Clinical Research (LongueVue Capital) Combines with South Texas Research Institute

January 10, 2023

Healthcare Services

Pinnacle Clinical Research, a LongueVue Capital portfolio company, has completed a combination with South Texas Research Institute (STRI). The deal expands Pinnacle's clinical site network to six dedicated locations, strengthens recruitment capabilities (notably for NASH/NAFLD trials) and increases geographic reach into the Rio Grande Valley.

LongueVue Capital Invests in Pinnacle Clinical Research

November 16, 2022

Healthcare Services

LongueVue Capital, a New Orleans-based private equity firm, completed a growth investment in Pinnacle Clinical Research, a San Antonio-based multi-location clinical trial site network specializing in complex therapeutic areas including hepatology (NAFLD/NASH). The capital from LVC is intended to support Pinnacle’s organic and inorganic growth, expand clinical trial capacity, and enhance operational capabilities across its Texas sites.

Summit Partners Makes Majority Growth Investment in LumaBridge

August 23, 2022

Healthcare Services

Summit Partners has made a majority growth equity investment in LumaBridge, an oncology-focused clinical research organization (CRO) headquartered in San Antonio, Texas. The capital will support LumaBridge’s expansion of clinical trial capabilities and enable the company to serve a larger number of emerging biopharma sponsors developing immuno-oncology therapies.

LongueVue Capital Recapitalizes Summit Plastics

January 20, 2021

Packaging

New Orleans-based private equity firm LongueVue Capital has completed a recapitalization and growth investment in Summit Plastics, partnering with CEO Tom Nathanson and the company's management team. Summit Plastics, headquartered in Summit, Mississippi, is a niche B2B manufacturer of custom LLDPE blown film and bags serving food & beverage, industrial, and healthcare end markets; Origin Bank provided senior debt for the transaction.